成AV免费大片黄在线观看 ,天堂中文8资源在线8,欧美三级在线播放,国内精品久久久久影视

2023-10-17

【Explore the future of the pharmaceutical industry】 Kingfriend will meet you in CPHI Barcelona!

Return

Previous Nothing at all Next Kindos creates the new record for fastest approval by FDA: Dacarbazine for Injection

Relevant recommendations

2024-08-07

NKF's subsidiary Kindos’s self-developed Ropivacaine Hydrochloride Injection gets FDA approval for marketing
2024-06-27

Meitheal Pharmaceuticals Strengthens Biologics Portfolio with an Exclusive Commercial Licensing Agreement for YUSIMRY®, a Biosimilar of Humira®
2024-05-20

Eptifibatide injection approved by USFDA，from Nanjing King-Friend subsidiary
2024-05-14

Enoxaparin Sodium Injection of NKF approved in Egypt
2024-05-14

Kindos’ (subsidiary of NKF) Bortezomib for injection getting approved by NMPA, submitted to NMPA and US FDA

Stock price

10.150

-0.25

?2025 Nanjing King-Friend Biochemical Pharmaceutical Co.Ltd蘇ICP備13012010號(hào)